Click Here to order online direct from Espère Healthcare Ltd
We are happy to discuss any questions or queries that you may have and also take orders over the phone. Just call us on 01462 346100 during office hours.
We can take orders by email, send a request to firstname.lastname@example.org with your delivery details, contact information and HCPC number and we can send Verrutop direct with a link for payment.
Verrutop is a topical solution for professional use providing painless treatment of difficult warts that is highly effective in just a few applications.
A unique, elevated combination
*As sensitivity varies, some patients may experience a slight, short-lived tingling after application of the product. This disappears after a few seconds.
One applied to the warts, it produces a painless mummification of the damaged tissue that causes the wart to detach automatically as healthy skin forms.
90% of patients cured after a maximum of 6 treatment sesions1.
Average: 3 sessions.
87% of patients cured after a maximum of 4 treatment sessions2.
49% of them cured after only one session
72% responded totally or partially to treatment with Verrutop®
59% disappeared after 1-3 applications of Verrutop®
while no effect was achieved by liquid nitrogen4
*. Verrutop in general is a painless treatment , altough some people may experience some temporary discomfort thatranges from a burning to slight tenderness or pain. 1. Galloni C, Balice Y, Fachetti M, Marchetti S, Motta L, Pisacane D. Efficacy and tolerability assessment of a new medical device containing a nitric-zinc complex to treat palmar, plantar and periungual warts: experience with 210 patients. Poster session presented at 27th EADV Congress; 2018 Sep 12-16; France, Paris. 2. Ciccarese G. Efﬁcacy Assessment of a Topically Applied Nitric–Zinc Complex Solution for the Treatment of External Anogenital Warts in 100 Patients. Dermatol Ther (Heidelb). 2019 Jun;9(2):327-335 3. . Guillet G, Jéroche F. Evaluation de l’efficacité et de la tolérance d’un traitement de verrues palmo-plantaires après échec thérapeutique avec cryothérapie, et de verrues péri-unguéales. Poitiers, France, Dermatologie pratique N°363-octobre 2012, p.9-10. 4. Viennet C et al. Assessment of the efficacy of a new formulation for plantar wart mummification: new experimental design and human papillomavirus identification .CED a 2012 British Association of Dermatologists Clinical and Experimental Dermatology, 38, 85–88